Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.

about

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.

Item

http://www.wikidata.org/entity/Q42317543

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.

@en

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.

@nl

type

Item

label

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.

@en

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.

@nl

prefLabel

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.

@en

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.

@nl

P1476

Targeting Notch enhances the efficacy of ERK inhibitors in BRAF-V600E melanoma.

@en

P2093

Ahmed A Samatar

http://www.w3.org/2001/XMLSchema#string

Denitsa Hristova

http://www.w3.org/2001/XMLSchema#string

Hsin-Yi Chen

http://www.w3.org/2001/XMLSchema#string

Jessie Villanueva

http://www.w3.org/2001/XMLSchema#string

Michael A Davies

http://www.w3.org/2001/XMLSchema#string

Min Xiao

http://www.w3.org/2001/XMLSchema#string

Minu Samanta

http://www.w3.org/2001/XMLSchema#string

Molly Halloran

http://www.w3.org/2001/XMLSchema#string

Patricia Brafford

http://www.w3.org/2001/XMLSchema#string

Patricia I Reyes-Uribe

http://www.w3.org/2001/XMLSchema#string

P2860

A landscape of driver mutations in melanoma

Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma

Pharmacodynamic effects and mechanisms of resistance to vemurafenib in patients with metastatic melanoma.

Reversing melanoma cross-resistance to BRAF and MEK inhibitors by co-targeting the AKT/mTOR pathway.

Mutations of the BRAF gene in human cancer

Cancer statistics, 2014

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

The novel gamma secretase inhibitor RO4929097 reduces the tumor initiating potential of melanoma

Acquired resistance to BRAF inhibitors mediated by a RAF kinase switch in melanoma can be overcome by cotargeting MEK and IGF-1R/PI3K

Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion

P304

71211-71222

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.12078

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Meenhard Herlyn

Katherine L Nathanson

Mizuho Fukunaga-Kalabis

Clemens Krepler

Adina Vultur

P577

2016-09-16T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27655717

http://www.w3.org/2001/XMLSchema#string

P932

5342073

http://www.w3.org/2001/XMLSchema#string